Literature DB >> 15123573

Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study.

Jorge R Kizer1, Donna K Arnett, Jonathan N Bella, Mary Paranicas, D C Rao, Michael A Province, Albert Oberman, Dalane W Kitzman, Paul N Hopkins, Jennifer E Liu, Richard B Devereux.   

Abstract

The degree to which ethnic differences in left ventricular structure among hypertensive adults are independent of clinical and hemodynamic factors remains uncertain. We assessed whether left ventricular mass and geometry differ between black and white hypertensives after accounting for differences in such factors. Our study group comprised 1060 black and 580 white hypertensive participants free of valvular or coronary disease in a population-based cohort. Blood pressure was measured during a clinic visit and echocardiography was performed using standardized protocols. After controlling for clinical and hemodynamic parameters (cardiac index, peripheral resistance index, and pulse pressure/stroke index), both left ventricular mass and relative wall thickness were higher in blacks than whites (173.9+/-30.9 versus 168.3+/-24.3 grams, P=0.006, and 0.355+/-0.055 versus 0.340+/-0.055 grams, P<0.001). Similarly, the adjusted risk of having left ventricular hypertrophy, whether indexed by height(2.7) or by body surface area, was greater for blacks than for whites (odds ratio: 1.80; 95% CI: 1.29 to 2.51; and odds ratio: 2.50; 95% CI: 1.58 to 3.96, respectively), and this was also true for concentric geometry (odds ratio: 2.28; 95% CI: 1.22 to 4.25). Further adjustment for relatedness in this genetic epidemiological study did not attenuate these differences. Our findings confirm the strong association between black ethnicity and increased left ventricular mass and relative wall thickness in hypertensive adults and demonstrate that these differences are independent of standard clinical and hemodynamic parameters. Whether such differences relate to distinct ambulatory pressure profiles or an ethnic propensity to cardiac hypertrophy requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123573     DOI: 10.1161/01.HYP.0000128738.94190.9f

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  72 in total

1.  Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.

Authors:  Amit Noheria; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2010-03-25       Impact factor: 2.689

Review 2.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

3.  Prevalence and Clinical Correlates of Left Ventricular Hypertrophy in Black Africans.

Authors:  Marcelo Perim Baldo; Mauer A Gonçalves; Daniel P Capingana; Pedro Magalhães; Amilcar B Tomé da Silva; José Geraldo Mill
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-06-28

4.  Prevalence of prehypertension and left ventricular hypertrophy.

Authors:  Jun-Ichi Oyama; Koichi Node
Journal:  Hypertens Res       Date:  2017-02-23       Impact factor: 3.872

5.  Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.

Authors:  Faraz S Ahmad; Xuan Cai; Katherine Kunkel; Ana C Ricardo; James P Lash; Dominic S Raj; Jiang He; Amanda H Anderson; Matthew J Budoff; Julie A Wright Nunes; Jason Roy; Jackson T Wright; Alan S Go; Martin G St John Sutton; John W Kusek; Tamara Isakova; Myles Wolf; Martin G Keane
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

Review 6.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

7.  Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Eileen O'Meara; Akshay S Desai; John F Heitner; Guichu Li; James Fang; Jean Rouleau; Michael R Zile; Valetin Markov; Vyacheslav Ryabov; Gilmar Reis; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-08-13       Impact factor: 8.790

Review 8.  Hypertension Treatment in Blacks: Discussion of the U.S. Clinical Practice Guidelines.

Authors:  Stephen K Williams; Joseph Ravenell; Sara Seyedali; Sam Nayef; Gbenga Ogedegbe
Journal:  Prog Cardiovasc Dis       Date:  2016-09-29       Impact factor: 8.194

Review 9.  Ventricular remodeling in heart failure with preserved ejection fraction.

Authors:  Amil M Shah
Journal:  Curr Heart Fail Rep       Date:  2013-12

10.  Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity.

Authors:  Edward P Havranek; Desiree B Froshaug; Caroline D B Emserman; Rebecca Hanratty; Mori J Krantz; Frederick A Masoudi; L Miriam Dickinson; John F Steiner
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.